Current risks of HeartMate II pump thrombosis: Non-parametric analysis of Interagency Registry for Mechanically Assisted Circulatory Support data
| Autor: | Randall C. Starling, Nicholas G. Smedira, Lucy Thuita, Christopher D. Pierce, John Ehrlinger, Eugene H. Blackstone, Nader Moazami |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Male
Pulmonary and Respiratory Medicine medicine.medical_specialty Risk Assessment Statistics Nonparametric Postoperative Complications Humans Medicine Registries Adverse effect Pump thrombosis Transplantation Heartmate ii business.industry Thrombosis Middle Aged medicine.disease Surgery Circulatory system Emergency medicine Female Heart-Assist Devices Implant Cardiology and Cardiovascular Medicine business Body mass index |
| Zdroj: | The Journal of Heart and Lung Transplantation. 34:1527-1534 |
| ISSN: | 1053-2498 |
| DOI: | 10.1016/j.healun.2015.10.027 |
| Popis: | Background Data from 3 institutions revealed an abrupt increase in HeartMate II (Thoratec) pump thrombosis starting in 2011, associated with 48% mortality at 6 months without transplantation or pump exchange. We sought to discover if the increase occurred nationwide in Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) data, and if so (1) determine if accelerated risk continued, (2) identify predictors, (3) investigate institutional variability, and (4) assess mortality after pump thrombosis. Methods From April 2008 to June 2014, 11,123 HeartMate II devices were implanted at 146 institutions. Machine learning, non-parametric Random Forests for Survival was used to explore risk-adjusted thrombosis based on 87 pre-implant and implant variables, including implant date. Results A total of 995 pumps thrombosed, with risk peaking within weeks of implant. The risk-adjusted increase in pump thrombosis began in 2010, reached a maximum in 2012, and then plateaued at a level that was 3.3-times higher than pre-2010. Pump exchange, younger age, and larger body mass index were important predictors, and institutional variability was largely explained by implant date, patient profile, and duration of support. The probability of death within 3 months after pump thrombosis was 24%. Conclusions Accelerated risk of HeartMate II thrombosis was confirmed by Interagency Registry for Mechanically Assisted Circulatory Support data, with risk subsequently leveling at a risk-adjusted rate higher than observed pre-2010. This elevated thrombosis risk emphasizes the need for improved mechanical circulatory support systems and post-market surveillance of adverse events. Clinicians cognizant of these new data should incorporate them into their and their patients' expectations and understanding of risks relative to those of transplantation and continued medical therapy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|